Lidocaine 18.18 mg/mL/Bupivacaine 2.27 recall: Sterility Concern
Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mL, supplied in 11 mL Sterile Syringes, Rx only, Compounded…
Why was Lidocaine 18.18 mg/mL/Bupivacaine 2.27 recalled?
Non-Sterility
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot# 041013-13 (also been written as "041013@13") Exp: 06/09/2013
- Product
- Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mL, supplied in 11 mL Sterile Syringes, Rx only, Compounded…
- Recalling firm
- Abrams Royal Pharmacy
- Quantity
- 50 syringes
- Distribution
- Texas
- Recall date
- November 26, 2014
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)